Edwards Lifesciences Corp (EW)vsKoninklijke Philips NV ADR (PHG)
EW
Edwards Lifesciences Corp
$82.50
+0.05%
HEALTHCARE · Cap: $48.94B
PHG
Koninklijke Philips NV ADR
$26.25
-2.27%
HEALTHCARE · Cap: $27.08B
Smart Verdict
WallStSmart Research — data-driven comparison
Koninklijke Philips NV ADR generates 194% more annual revenue ($17.83B vs $6.07B). EW leads profitability with a 17.7% profit margin vs 5.0%. PHG appears more attractively valued with a PEG of 0.36. EW earns a higher WallStSmart Score of 53/100 (C-).
EW
Buy53
out of 100
Grade: C-
PHG
Hold49
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-537.7%
Fair Value
$12.44
Current Price
$82.50
$70.06 premium
Margin of Safety
-340.5%
Fair Value
$7.28
Current Price
$26.25
$18.97 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 23.7%
Growing faster than its price suggests
Revenue surging 110.0% year-over-year
Reasonable price relative to book value
Generating 1.3B in free cash flow
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Earnings declined 76.6%
Moderate valuation
ROE of 7.8% — below average capital efficiency
5.0% margin — thin
Earnings declined 50.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : EW
The strongest argument for EW centers on Operating Margin. Profitability is solid with margins at 17.7% and operating margin at 23.7%. Revenue growth of 13.3% demonstrates continued momentum.
Bull Case : PHG
The strongest argument for PHG centers on PEG Ratio, Revenue Growth, Price/Book. Revenue growth of 110.0% demonstrates continued momentum. PEG of 0.36 suggests the stock is reasonably priced for its growth.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 46.0x leaves little room for execution misses.
Bear Case : PHG
The primary concerns for PHG are P/E Ratio, Return on Equity, Profit Margin.
Key Dynamics to Monitor
EW profiles as a mature stock while PHG is a hypergrowth play — different risk/reward profiles.
PHG carries more volatility with a beta of 0.94 — expect wider price swings.
PHG is growing revenue faster at 110.0% — sustainability is the question.
PHG generates stronger free cash flow (1.3B), providing more financial flexibility.
Bottom Line
EW scores higher overall (53/100 vs 49/100), backed by strong 17.7% margins and 13.3% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →Koninklijke Philips NV ADR
HEALTHCARE · MEDICAL DEVICES · USA
Koninklijke Philips NV is a healthcare technology company in North America, Greater China and internationally. The company is headquartered in Amsterdam, the Netherlands.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?